15 - 17 November 2021 | EST (UTC-5)

Rolf Jautelat

Vice President Medicinal Chemistry
Bayer AG
Rolf Jautelat
Rolf Jautelat is VP Medicinal Chemistry at Bayer Pharmaceuticals. Throughout his career he has been involved in drug discovery projects aiming for cardiovascular drugs, targeted anti-cancer agents, antibody-drug conjugates and new ophthalmic agents. Furthermore, he was involved in the design of Chemistry Information Systems, first at Schering AG and then later at Bayer. Rolf received a Ph.D. in synthetic chemistry from the University of Hannover followed by postdoctoral studies at the Scripps Research Institute, La Jolla.


No data was found

Download Brochure

Full details regarding the Discovery Series: Virtual are available for download in the Conference Brochure